Currently out of the existing stock ratings of Evan Seigerman, 356 are a BUY (68.07%), 144 are a HOLD (27.53%), 23 are a SELL (4.4%).
Analyst Evan Seigerman, currently employed at BMO, has had 68.74% of price targets met with an average potential upside of 29.94%, reached in 248 days on average.
Evan Seigerman has documented 1,035 price targets and ratings displayed on 40 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on IRON, Disc Medicine at 19-Oct-2026.
Analyst best performing recommendations are on TERN (TERNS PHARMACEUTICALS).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) on 2/5/2026. The price target of $45 was fulfilled within 1 day with a profit of $3.72 (9.01%), with a performance score of 90.12.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Sep-2023
$5
2 years 11 months 8 days ago
(07-Dec-2023)
0/6 (0%)
$4.4 (733.33%)
Buy Since 10-Oct-2018
$4
$2.87 (253.98%)
$180
4 years 11 months 14 days ago
(01-Dec-2021)
1/4 (25%)
$-8.43 (-67.82%)
161
Buy Since 22-Sep-2015
$80
$78.87 (6979.65%)
$140
5 years 7 months 30 days ago
(16-Mar-2021)
0/4 (0%)
$42.8 (115.05%)
Sell Since 13-Aug-2020
$16.6
$15.47 (1369.03%)
$16.8
6 years 9 days ago
(06-Nov-2020)
5/6 (83.33%)
$-12.4 (-42.76%)
268
Buy Since 16-Aug-2016
$120
$118.87 (10519.47%)
$140
7 years 6 months 6 days ago
(09-May-2019)
0/4 (0%)
$56.4 (88.68%)
Which stock is Evan Seigerman most bullish on?
Which stock is Evan Seigerman most reserved on?
What Year was the first public recommendation made by Evan Seigerman?
